Amy L Olson

Summary

Publications

  1. ncbi Idiopathic pulmonary fibrosis: diagnosis and epidemiology
    Amy L Olson
    Interstitial Lung Disease Program, Division of Pulmonary and Critical Care Medicine, Autoimmune Lung Center, National Jewish Health, Denver, CO 80206, USA
    Clin Chest Med 33:41-50. 2012
  2. ncbi Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
    D B Sprunger
    Interstitial Lung Disease Program and Autoimmune Lung Center, Division of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, CO 80220, USA
    Eur Respir J 39:125-32. 2012
  3. ncbi Rheumatoid arthritis-interstitial lung disease-associated mortality
    Amy L Olson
    Division of Pulmonary and Critical Care Medicine, Interstitial Lung Disease Program, and Autoimmune Lung Center, National Jewish Health, Denver, Colorado, USA
    Am J Respir Crit Care Med 183:372-8. 2011
  4. ncbi Seasonal variation: mortality from pulmonary fibrosis is greatest in the winter
    Amy L Olson
    Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Chest 136:16-22. 2009
  5. ncbi Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death
    Jeffrey J Swigris
    Autoimmune Lung Center and Interstitial Lung Disease Program, National Jewish Health, Denver, CO 80206, USA
    Respir Med 106:588-93. 2012
  6. ncbi Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007
    Jeffrey J Swigris
    Autoimmune Lung Center and Interstitial Lung Disease Program, National Jewish Health, Southside Building, Office No G011, 1400 Jackson St, Denver, CO 80206, USA
    Chest 140:1261-6. 2011
  7. ncbi Sarcoidosis-related mortality in the United States from 1988 to 2007
    Jeffrey J Swigris
    Autoimmune Lung Center and Interstitial Lung Disease Program, National Jewish Health, Denver, CO 80206, USA
    Am J Respir Crit Care Med 183:1524-30. 2011
  8. ncbi Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series
    Amy L Olson
    Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, 4200 East Ninth Ave, C272, Denver, CO 80262, USA
    Chest 134:844-50. 2008
  9. ncbi Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis
    Jeffrey J Swigris
    Interstitial Lung Disease Program and Autoimmune Lung Center, National Jewish Health, Denver, Colorado 80206, USA
    Respirology 16:439-45. 2011
  10. ncbi Eosinophilic lung diseases
    Evans R Fernandez Perez
    Interstitial Lung Disease Program, Autoimmune Lung Center, National Jewish Health, Denver, CO 80206, USA
    Med Clin North Am 95:1163-87. 2011

Detail Information

Publications12

  1. ncbi Idiopathic pulmonary fibrosis: diagnosis and epidemiology
    Amy L Olson
    Interstitial Lung Disease Program, Division of Pulmonary and Critical Care Medicine, Autoimmune Lung Center, National Jewish Health, Denver, CO 80206, USA
    Clin Chest Med 33:41-50. 2012
    ..This article summarizes the approach to diagnosing IPF and reviews epidemiologic data on IPF...
  2. ncbi Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
    D B Sprunger
    Interstitial Lung Disease Program and Autoimmune Lung Center, Division of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, CO 80220, USA
    Eur Respir J 39:125-32. 2012
    ..Those with VTE and pulmonary fibrosis died at a younger age than those with pulmonary fibrosis alone. These data suggest a link between a pro-fibrotic and a pro-coagulant state...
  3. ncbi Rheumatoid arthritis-interstitial lung disease-associated mortality
    Amy L Olson
    Division of Pulmonary and Critical Care Medicine, Interstitial Lung Disease Program, and Autoimmune Lung Center, National Jewish Health, Denver, Colorado, USA
    Am J Respir Crit Care Med 183:372-8. 2011
    ..Mortality rates from rheumatoid arthritis-associated interstitial lung disease (RA-ILD) are largely unknown...
  4. ncbi Seasonal variation: mortality from pulmonary fibrosis is greatest in the winter
    Amy L Olson
    Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Chest 136:16-22. 2009
    ..Our objective was to determine if mortality rates from IPF and/or PF of any cause exhibit seasonal variation...
  5. ncbi Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death
    Jeffrey J Swigris
    Autoimmune Lung Center and Interstitial Lung Disease Program, National Jewish Health, Denver, CO 80206, USA
    Respir Med 106:588-93. 2012
    ..In studies of idiopathic pulmonary fibrosis (IPF), whites makeup the vast majority of subjects. Whether ethnic/racial differences in idiopathic pulmonary fibrosis occur in the general population is unknown...
  6. ncbi Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007
    Jeffrey J Swigris
    Autoimmune Lung Center and Interstitial Lung Disease Program, National Jewish Health, Southside Building, Office No G011, 1400 Jackson St, Denver, CO 80206, USA
    Chest 140:1261-6. 2011
    ..A recently published report from the United Kingdom suggested an association between sarcoidosis and pulmonary embolism (PE). We sought to examine whether this association was present among US decedents with sarcoidosis...
  7. ncbi Sarcoidosis-related mortality in the United States from 1988 to 2007
    Jeffrey J Swigris
    Autoimmune Lung Center and Interstitial Lung Disease Program, National Jewish Health, Denver, CO 80206, USA
    Am J Respir Crit Care Med 183:1524-30. 2011
    ..Objectives: To examine mortality rates and underlying causes of death among United States decedents with sarcoidosis from 1988-2007...
  8. ncbi Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series
    Amy L Olson
    Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, 4200 East Ninth Ave, C272, Denver, CO 80262, USA
    Chest 134:844-50. 2008
    ..While best described in patients with IPF, they have also been reported in patients with other forms of interstitial lung disease. We sought to determine if this same phenomenon occurs in patients with hypersensitivity pneumonitis (HP)...
  9. ncbi Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis
    Jeffrey J Swigris
    Interstitial Lung Disease Program and Autoimmune Lung Center, National Jewish Health, Denver, Colorado 80206, USA
    Respirology 16:439-45. 2011
    ..In patients with IPF, we sought to validate that abnormal heart rate recovery at 1 min (HRR1) after six-minute walk test (6MWT) predicts mortality and to explore the relationship between abnormal HRR1 and pulmonary hypertension (PH)...
  10. ncbi Eosinophilic lung diseases
    Evans R Fernandez Perez
    Interstitial Lung Disease Program, Autoimmune Lung Center, National Jewish Health, Denver, CO 80206, USA
    Med Clin North Am 95:1163-87. 2011
    ..This review focuses on the clinical features, general diagnostic workup, and management of the eosinophilic lung diseases...
  11. ncbi A 63-year-old man with a persistent pulmonary infiltrate and pleural effusion
    Amy L Olson
    Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, 4200 East Ninth Ave, C272, Denver, CO 80262, USA
    Chest 130:1929-34. 2006
  12. ncbi Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease
    Jeffrey J Swigris
    Autoimmune Kung Center, Interstitial Lung Disease Program, National Jewish Medical and Research Center, 1400 Jackson St, Molly Blank J229, Denver, CO 80206, USA
    Chest 130:30-6. 2006
    ..In this study, our objectives were to examine the safety and tolerability of mycophenolate mofetil (MMF) and to determine its impact on lung function in patients with CTD-ILD...